Neoadjuvant Chemo Flops Versus Upfront Surgery for Resectable Pancreatic Cancer
(MedPage Today) -- CHICAGO -- Neoadjuvant chemotherapy failed to match upfront surgery for survival in resectable pancreatic cancer, a small randomized trial showed.
Unexpectedly, patients assigned to surgery first lived more than a year longer... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - June 4, 2023 Category: Surgery Source Type: news
UK trials for cancer breath tests reach final stages
Quick and simple tests in GP surgeries could detect cancer of the oesophagus, stomach, pancreas, colon or liverSimply blowing into a bag at a GP ’s surgery could show that a patient has cancer. That is the aim of an ambitious new project that is going through its final clinical trials in the UK. If successful,cancer breath tests could be used in a few years in order topinpoint a range of tumours in the early stages of their development.The technique is primarily aimed atdetecting cancers of the gut, including those of the oesophagus, stomach, pancreas and colon, but could also be used to pinpoint cases of liver cancer. I...
Source: Guardian Unlimited Science - June 4, 2023 Category: Science Authors: Robin McKie Science Editor Tags: Cancer Health Medical research Science Medicine UK news Source Type: news
Olaparib Gains BRCA-Mutated Prostate Cancer Indication Olaparib Gains BRCA-Mutated Prostate Cancer Indication
The new indication adds to the PARP inhibitor ' s previous approvals for HRR-mutated metastatic castration-resistant prostate cancer as well as for ovarian, breast, and pancreatic cancer indications.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - June 1, 2023 Category: Urology & Nephrology Tags: Hematology-Oncology News Alert Source Type: news
ASCO: Minimally Invasive Noninferior to Open Surgery for Pancreatic Cancer
THURSDAY, June 1, 2023 -- For patients with resectable pancreatic cancer, minimally invasive distal pancreatectomy (MIDP) is noninferior to open distal pancreatectomy (ODP), according to a study presented at the annual meeting of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2023 Category: Pharmaceuticals Source Type: news
Six warning signs of pancreatic cancer that can appear 'months' before diagnosis
Pain that is made worse by eating and drinking could be a red flag sign, according to a doctor. (Source: Daily Express - Health)
Source: Daily Express - Health - May 28, 2023 Category: Consumer Health News Source Type: news
Awe-inspiring stories from Cancer Research UK's drive to raise millions to help conquer disease
The 41-year-old mother-of-two with incurable breast cancer, running to give hope to others facing an uncertain future. The woman racing to boost funding for pancreatic cancer research. (Source: the Mail online | Health)
Source: the Mail online | Health - May 27, 2023 Category: Consumer Health News Source Type: news
Minimally Invasive Surgery May Be Good Option for People With Pancreatic Cancer
FRIDAY, May 26, 2023 -- Minimally invasive surgery works just as well as full-scale open surgery in removing early-stage pancreatic cancers, allowing patients a faster recovery with less infection risk, a new clinical trial has found.
The ability to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 26, 2023 Category: General Medicine Source Type: news
Roche to present new data in blood cancers and solid tumours from its broad portfolio at ASCO 2023
Basel, 26 May 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will be presenting new data on six approved and investigational medicines across ten cancer types at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, held 2 – 6 June. Highlights include new data spanning treatments for lymphoma and hepatocellular carcinoma (HCC):Developing new treatment options for people with blood cancersExtended follow-up data for Columvi ® (glofitamab) of almost two years (20 months) from the pivotal phase II NP30179 study, further investigating the potential of fixed-duration Columvi to provide durable responses in people...
Source: Roche Investor Update - May 26, 2023 Category: Pharmaceuticals Source Type: news
Minimally Invasive vs Open Surgery in Pancreatic Cancer Minimally Invasive vs Open Surgery in Pancreatic Cancer
Patients who are to undergo surgery for early-stage pancreatic cancer can now choose between minimally invasive and open approaches following a trial showing similar outcomes with both approaches.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 25, 2023 Category: Surgery Tags: Hematology-Oncology News Source Type: news
Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effective
(MedPage Today) -- CHICAGO -- A minimally invasive approach for operable pancreatic cancer proved safe and just as effective in terms of radical resection rates as open surgery, findings from the international DIPLOMA trial showed.
For the study... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - May 25, 2023 Category: Surgery Source Type: news
Automated Insulin Delivery System, Not an Artificial Pancreas Automated Insulin Delivery System, Not an Artificial Pancreas
Anne L. Peters, MD, explains why the term artificial pancreas is wrong and why automated insulin delivery system is correct.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 24, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
What to Know About High Triglycerides
Discussions about heart health often center around blood pressure and cholesterol, with factors like poor sleep, smoking, family history of heart disease, and chronic stress thrown in. However, there’s one variable that doesn’t get covered as often, even though it can be an important indicator of cardiovascular risk: triglycerides.
“We don’t really talk about triglycerides very much, especially compared to cholesterol, but they’re actually an essential part of understanding heart health,” says Dr. Adriana Quinones-Camacho, a cardiologist at NYU Langone Health in New York. “For some...
Source: TIME: Health - May 23, 2023 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized healthscienceclimate heart health Source Type: news
An mRNA vaccine to treat pancreatic cancer
A personalized mRNA vaccine against pancreatic cancer created a strong anti-tumor immune response in half the participants in a small study. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - May 22, 2023 Category: Consumer Health News Source Type: news
FDA Clears iLet Bionic Pancreas Insulin Delivery System FDA Clears iLet Bionic Pancreas Insulin Delivery System
The FDA has cleared a next-generation insulin pump and software combination that provides greater automation than current"artificial pancreas" systems.FDA Approvals (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 19, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news
Five warning signs of pancreatic cancer revealed after death of The Smiths bassist Andy Rourke, 59
As The Smiths bassist Andy Rourke dies aged 59 from pancreatic cancer we look at some of early warning signs of the disease that is so subtle it is often only caught in the later, deadlier, stages. (Source: the Mail online | Health)
Source: the Mail online | Health - May 19, 2023 Category: Consumer Health News Source Type: news
